Nutra Pharma Corp. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Rotenberg Meril Solomon Bertiger & Guttilla, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
Mar. 22 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
Mar. 22 | Nutra Pharma Corporation Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 706K | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- NPHC Stock
- News Nutra Pharma Corp.
- Nutra Pharma Corp. Auditor Raises 'Going Concern' Doubt